Benjamin Jackson is E.V.P., General Counsel of MYRIAD GENETICS INC. Currently has a direct ownership of 107,029 shares of MYGN, which is worth approximately $1.61 Million. The most recent transaction as insider was on Mar 24, 2021, when has been sold 18,879 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 107K
0% 3M change
0% 12M change
Total Value Held $1.61 Million

Benjamin Jackson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 24 2021
BUY
Grant, award, or other acquisition
-
18,879 Added 14.99%
107,029 Common Stock
Oct 08 2020
BUY
Grant, award, or other acquisition
-
29,784 Added 25.25%
88,150 Common Stock
Sep 30 2020
SELL
Sale (or disposition) back to the issuer
$5,425 $13.04 p/Share
416 Reduced 0.71%
58,366 Common Stock

Also insider at

SERA
SERA PROGNOSTICS, INC. Healthcare
BJ

Benjamin Jackson

E.V.P., General Counsel
Salt Lake City, UT

Track Institutional and Insider Activities on MYGN

Follow MYRIAD GENETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN